| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |